Argent BioPharma Limited

0.032

0.000

Volume:217.06K

Turnover:7K

Market Cap:3.73M

PE:-0.26

High:0.032

Open:0.032

Low:0.031

Close:0.032

52wk High:0.145

52wk Low:0.031

Shares:116.61M

Float Shares:27.70M

Volume Ratio:1.76

T/O Rate:0.78%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.123

EPS(LYR):-0.312

ROE:--

ROA:-243.04%

PB:-0.44

PE(LYR):-0.10

Loading ...

Overview Company News Filings

Argent BioPharma H1 revenue jumps 39.0x to AUD 171,499

Reuters

·

Feb 27

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/RGT.AU/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RGT.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"RGT.AU\",,,,,undefined,":{"symbol":"RGT.AU","market":"AU","secType":"STK","nameCN":"Argent BioPharma Limited","latestPrice":0.032,"timestamp":1788143642394,"preClose":0.032,"halted":0,"volume":217064,"delay":0,"changeRate":0,"nameEN":"Argent BioPharma Limited","floatShares":27704074,"shares":116609584,"eps":-0.123189,"marketStatus":"Trading","change":0,"latestTime":"08-31 12:34:38 AEST","open":0.032,"high":0.032,"low":0.031,"amount":6838,"amplitude":0.03125,"askPrice":0.034,"askSize":1901,"bidPrice":0.032,"bidSize":39401,"shortable":3,"etf":0,"ttmEps":-0.123189,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1788156000000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":0.032,"openAndCloseTimeList":[[1788134400000,1788156000000]],"volumeRatio":1.758606,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"RGT.AU","preClose":0.037,"auctionPrice":0.034,"auctionVolume":3223,"auction":3,"marketStatus":"盘后竞价","timestamp":1787810705229}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"RGT.AU\",,,,,undefined,":{"symbol":"RGT.AU","floatShares":27704074,"roa":"-243.04%","roe":"--","lyrEps":-0.312116,"volumeRatio":1.758606,"shares":116609584,"dividePrice":0,"high":0.032,"amplitude":0.03125,"preClose":0.032,"low":0.031,"week52Low":0.031,"pbRate":"-0.44","psRate":"10.73","week52High":0.145,"institutionHeld":0,"latestPrice":0.032,"committee":0.907946,"eps":-0.123189,"divideRate":0,"volume":217064,"delay":0,"ttmEps":-0.123189,"open":0.032,"prevYearClose":0.07,"prevWeekClose":0.032,"prevMonthClose":0.04,"prevQuarterClose":0.036,"fiveDayClose":0.037,"twentyDayClose":0.038,"sixtyDayClose":0.036},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RGT.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2024-09-23","symbol":"RGT.AU","reason":null,"defaultRemindTime":1727049600000,"announcedDate":"2024-08-15","type":"delisting","dateTimestamp":1727013600000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RGT.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RGT.AU\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2614884316","title":"Argent BioPharma H1 revenue jumps 39.0x to AUD 171,499","url":"https://stock-news.laohu8.com/highlight/detail?id=2614884316","media":"Reuters","labels":["dataReport","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614884316?lang=en_us&edition=fundamental","pubTime":"2026-02-27 15:20","pubTimestamp":1772176848,"startTime":"0","endTime":"0","summary":"Argent BioPharma reported revenue from ordinary activities of AUD 171,499 for H1 ended 31 December 2025, a 39.0x increase, and a net loss attributable to members of AUD 2.9 million . Net tangible assets per share were (0.1) cents at 31 December 2025. Cash and cash equivalents were AUD 1.5 million at 31 December 2025, while net cash used in operating activities was AUD 2.6 million for H1. During the period, Argent BioPharma began formal supply of EU-GMP cannabinoid API to University Medical Centre Ljubljana for drug-resistant epilepsy, and published a peer-reviewed CannEpil case study in treatment-resistant epilepsy. The company also cited an independent in vivo study by the University of South Florida showing up to 85% survival in treated mice for ArtemiC in a viral inflammatory model. In December 2025, the group liquidated its Slovenian subsidiary following a decision to cease operations at its Slovenia manufacturing facility, recording a AUD 55,395 loss on liquidation. Subsequent to ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260227:nNDL9BBpN2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"Argent BioPharma H1 revenue jumps 39.0x to AUD 171,499","news_tag":"dataReport,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RGT.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":21,"code":"91000000","status":"200"}]}}